LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_006218.4:c.3G>A
PIK3CA
· NP_006209.2:p.(Met1?)
· NM_006218.4
GRCh37: chr3:178916616 G>A
·
GRCh38: chr3:179198828 G>A
Gene:
PIK3CA
Transcript:
NM_006218.4
Final call
VUS
PM2 supporting
Variant details
Gene
PIK3CA
Transcript
NM_006218.4
Protein
NP_006209.2:p.(Met1?)
gnomAD AF
0.0 (v4.1)
ClinVar
OncoKB
Inconclusive
Classification rationale
Interpretation summary
Generated evidence synthesis
1
VUS: PM2 supporting is met because the variant has 0 of 1,513,740 alleles and 0 homozygotes in gnomAD v4.1.
Final determination:
Under the generic ACMG/AMP 2015 fallback, one supporting criterion alone does not meet any pathogenic, likely pathogenic, benign, or likely benign combination threshold, resulting in a Variant of Uncertain Significance.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | N/A | Not applicable: the governing VCEP identifies PIK3CA brain-malformation disease as gain of function, so PVS1 is not used for this initiation-codon variant. |
cspec
|
| PS1 | N/A | PS1 (Richards et al. 2015, PMID:25741868) requires the same amino acid change as a previously established pathogenic variant, evaluated regardless of the underlying nucleotide change. NM_006218.4:c.3G>A in PIK3CA is a variant affecting the translation-initiation codon (Met1) predicted to produce NP_006209.2:p.(Met1?). As a result, no altered amino acid exists at this position to compare against any previously established pathogenic missense variant, so PS1's structural prerequisite is not met by this variant class. This determination was made deterministically from the variant's consequence class, prior to LLM adjudication, because no structured VCEP criteria-combination framework governs this case (framework_complete=false; framework_mode=unstructured_ruleset); the generic ACMG/AMP 2015 fallback applies. |
generic_acmg_combination_rules
|
| PS2 | Not assessed | Not assessed: no proband, parental testing, maternity/paternity confirmation, or tissue allele-fraction data are available to meet the VCEP PS2 criteria. |
cspec
|
| PS3 | Not assessed | Not assessed: available functional papers do not test c.3G>A (p.M1?), so no variant-specific damaging assay result meets the VCEP PS3 requirements. |
cspec
PMID:29533785
PMID:31996845
|
| PS4 | Not assessed | Not assessed: the variant is absent from gnomAD, but no verified affected-individual phenotype observation was available to assign Table 2A PS4 points. |
cspec
gnomad_v2
gnomad_v4
gnomad_canada
PMID:29533785
PMID:31996845
|
| PM1 | N/A | PM1 (Richards et al. 2015, PMID:25741868) applies to a missense variant located in a mutational hot spot and/or a critical, well-established functional domain without benign variation. NM_006218.4:c.3G>A in PIK3CA is a variant affecting the translation-initiation codon (Met1) predicted to produce NP_006209.2:p.(Met1?). As a result, no altered residue exists to evaluate for mutational hot-spot or critical-domain membership, so PM1's structural prerequisite is not met by this variant class. This determination was made deterministically from the variant's consequence class, prior to LLM adjudication, because no structured VCEP criteria-combination framework governs this case (framework_complete=false; framework_mode=unstructured_ruleset); the generic ACMG/AMP 2015 fallback applies. |
generic_acmg_combination_rules
|
| PM2 | Met | Met at supporting: the variant has 0/1,513,740 alleles and 0 homozygotes in gnomAD v4.1, within the VCEP one-person maximum. |
cspec
gnomad_v2
gnomad_v4
|
| PM3 | N/A | Not applicable: the VCEP specifies PM3 is not applicable because disease-causing PIK3CA variants are heterozygous. |
cspec
|
| PM4 | N/A | PM4 (Richards et al. 2015, PMID:25741868) applies to protein length changes: in-frame insertions/deletions in a non-repetitive region, or stop-loss variants that extend the protein past the reference stop codon. NM_006218.4:c.3G>A in PIK3CA is a variant affecting the translation-initiation codon (Met1) predicted to produce NP_006209.2:p.(Met1?). As a result, no change in protein length occurs, so there is nothing for this criterion to evaluate, so PM4's structural prerequisite is not met by this variant class. This determination was made deterministically from the variant's consequence class, prior to LLM adjudication, because no structured VCEP criteria-combination framework governs this case (framework_complete=false; framework_mode=unstructured_ruleset); the generic ACMG/AMP 2015 fallback applies. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| PM5 | N/A | PM5 (Richards et al. 2015, PMID:25741868) requires a novel missense change at an amino acid residue where a different missense change has previously been determined to be pathogenic. NM_006218.4:c.3G>A in PIK3CA is a variant affecting the translation-initiation codon (Met1) predicted to produce NP_006209.2:p.(Met1?). As a result, no missense change exists at this residue to compare against a different pathogenic missense change at the same position, so PM5's structural prerequisite is not met by this variant class. This determination was made deterministically from the variant's consequence class, prior to LLM adjudication, because no structured VCEP criteria-combination framework governs this case (framework_complete=false; framework_mode=unstructured_ruleset); the generic ACMG/AMP 2015 fallback applies. |
generic_acmg_combination_rules
|
| PM6 | N/A | Not applicable: the VCEP explicitly routes assumed de novo evidence without parental confirmation to PS2 rather than allowing PM6. |
cspec
|
| PP1 | N/A | Not applicable: the VCEP excludes PP1 for this disorder because its disease-causing variants are de novo or mosaic. |
cspec
|
| PP2 | N/A | PP2 (Richards et al. 2015, PMID:25741868) applies to a missense variant in a gene with a low rate of benign missense variation, where missense variants are a common mechanism of disease. NM_006218.4:c.3G>A in PIK3CA is a variant affecting the translation-initiation codon (Met1) predicted to produce NP_006209.2:p.(Met1?). As a result, the gene's missense-constraint properties are irrelevant because no missense change is present to evaluate, so PP2's structural prerequisite is not met by this variant class. This determination was made deterministically from the variant's consequence class, prior to LLM adjudication, because no structured VCEP criteria-combination framework governs this case (framework_complete=false; framework_mode=unstructured_ruleset); the generic ACMG/AMP 2015 fallback applies. |
generic_acmg_combination_rules
|
| PP3 | N/A | Not applicable: initiation-loss variant p.(Met1?) is outside the VCEP's PP3 scope, which excludes this gain-of-function consequence. |
cspec
|
| PP4 | N/A | Not applicable: the Brain Malformations VCEP explicitly accounts for phenotype-specific evidence under PS4 rather than PP4. |
cspec
|
| PP5 | Not met | Not met: ClinVar has no exact-variant expert-panel pathogenic or likely pathogenic classification for NM_006218.4:c.3G>A. |
clinvar
cspec
|
| BA1 | Not met | Not met: gnomAD v4.1 allele frequency is 0/1,513,740 (0%), below the VCEP BA1 threshold of >0.0926%. |
cspec
gnomad_v2
gnomad_v4
|
| BS1 | Not met | Not met: gnomAD v4.1 allele frequency is 0/1,513,740 (0%), below the VCEP BS1 threshold of >0.0185%. |
cspec
gnomad_v2
gnomad_v4
|
| BS2 | Not met | Not met: gnomAD v4.1 reports 0 homozygotes, below the VCEP requirement of at least 3 homozygotes or 3 qualifying family observations. |
cspec
gnomad_v4
|
| BS3 | Not assessed | Not assessed: no fetched functional paper tests c.3G>A (p.M1?) and reports a validated normal-function result required for BS3. |
cspec
PMID:29533785
PMID:31996845
|
| BS4 | N/A | Not applicable: the VCEP excludes BS4 because this disorder is evaluated using de novo, germline-mosaic, or post-zygotic mechanisms. |
cspec
|
| BP1 | N/A | BP1 (Richards et al. 2015, PMID:25741868) applies to a missense variant in a gene for which primarily truncating variants are known to cause disease. NM_006218.4:c.3G>A in PIK3CA is a variant affecting the translation-initiation codon (Met1) predicted to produce NP_006209.2:p.(Met1?). As a result, the gene's truncating-variant mechanism is irrelevant because no missense change is present to evaluate, so BP1's structural prerequisite is not met by this variant class. This determination was made deterministically from the variant's consequence class, prior to LLM adjudication, because no structured VCEP criteria-combination framework governs this case (framework_complete=false; framework_mode=unstructured_ruleset); the generic ACMG/AMP 2015 fallback applies. |
generic_acmg_combination_rules
|
| BP2 | Not assessed | Not assessed: no documented cis/trans PIK3CA pathogenic-variant pair or phase result is available for NM_006218.4:c.3G>A. |
cspec
|
| BP3 | N/A | BP3 (Richards et al. 2015, PMID:25741868) applies to in-frame insertions/deletions located in a repetitive region without a known function. NM_006218.4:c.3G>A in PIK3CA is a variant affecting the translation-initiation codon (Met1) predicted to produce NP_006209.2:p.(Met1?). As a result, the variant does not alter protein length within a repeat region, so there is nothing for this criterion to evaluate, so BP3's structural prerequisite is not met by this variant class. This determination was made deterministically from the variant's consequence class, prior to LLM adjudication, because no structured VCEP criteria-combination framework governs this case (framework_complete=false; framework_mode=unstructured_ruleset); the generic ACMG/AMP 2015 fallback applies. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| BP4 | N/A | Not applicable: initiation-loss variant p.(Met1?) is neither synonymous, intronic, nor UTR, the VCEP-defined BP4 scope. |
cspec
|
| BP5 | Not assessed | Not assessed: no case was documented in which this exact variant co-occurred with a confirmed alternate molecular basis in another gene. |
cspec
|
| BP6 | Not met | Not met: ClinVar has no exact-variant expert-panel benign or likely benign classification for NM_006218.4:c.3G>A. |
clinvar
cspec
|
| BP7 | N/A | BP7 (Richards et al. 2015, PMID:25741868) is defined for a synonymous (silent) variant for which splicing prediction algorithms predict no impact to the splice consensus sequence and the nucleotide is not highly conserved. NM_006218.4:c.3G>A in PIK3CA is a variant affecting the translation-initiation codon (Met1) predicted to produce NP_006209.2:p.(Met1?). As a result, the encoded protein sequence is altered, so the criterion's silent-variant premise does not hold regardless of any splicing prediction, so BP7's structural prerequisite is not met by this variant class. This determination was made deterministically from the variant's consequence class, prior to LLM adjudication, because no structured VCEP criteria-combination framework governs this case (framework_complete=false; framework_mode=unstructured_ruleset); the generic ACMG/AMP 2015 fallback applies. |
generic_acmg_combination_rules
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.